Do Young Kim

Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea

Jae Seung Lee, Kwanjoo Lee, Do Young Kim, 2023, Life Cycle.

Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia

Do Young Kim, Sung Hoon Choi, 2024, Cancers.

Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.

B. Kim, Ja Kyung Yoon, Jae Seung Lee, 2024, Yonsei medical journal.

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide

Do Young Kim, 2024, Journal of liver cancer.

Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere.

B. Kim, Sung-Wook Moon, Gyoung Min Kim, 2024, Cardiovascular and interventional radiology.

T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Kyung Joo Cho, Hye Jung Park, H. Lee, 2024, International journal of molecular sciences.